Patents
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
07/2010
07/29/2010US20100187515 Use of a Precursor of an N-Dopant for Doping an Organic Semiconductive Material, Precursor and Electronic or Optoelectronic Component
07/29/2010CA2750777A1 Bicyclic heterocyclic spiro compounds
07/29/2010CA2750106A1 Poly (adp-ribose) polymerase (parp) inhibitors
07/29/2010CA2749807A1 A method for determination of sirolimus stability and process for preparing its stable form
07/29/2010CA2749217A1 Compositions and methods for inhibition of the jak pathway
07/28/2010EP2210893A1 Polymorphous forms of rifaximin as antibiotics
07/28/2010EP2209790A2 Equilibrative nucleoside transporter ent1 inhibitors
07/28/2010EP1458392B9 Acridones as inhibitors of impdh enzyme
07/28/2010EP1250135B1 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders
07/28/2010CN1974596B 丙型肝炎病毒抑制剂 Hepatitis C virus inhibitors
07/27/2010US7763738 ceramide-like inhibitors; novel intermediates formed during the synthesis; Glycosphingolipids
07/27/2010US7763734 Synthesis, structure and use of bisoxazolidines for asymmetric catalysis and synthesis
07/27/2010US7763606 2,4-benzodiazepine derivatives, used for treating cardiovascular diseases, cognitive and neurodegenerative diseases
07/27/2010CA2463084C Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity
07/27/2010CA2457034C Ophthalmic composition comprising an ascomycin
07/22/2010WO2010082050A1 Macrocyclic and 7-aminoalkyl-substituted benzoxazocines for treatment of hepatitis c infections
07/22/2010WO2010081877A1 Nitric oxide furoxan derivative compounds endowed with antitumoral activity
07/22/2010WO2010081488A1 Nitric oxide furoxan derivative compounds endowed with antitumoral activity
07/22/2010US20100184992 Stable neutral nitric oxide source
07/22/2010US20100184755 Protein kinase c inhibitors and uses thereof
07/21/2010EP2208730A1 Polymorphic forms of rifaximin, processes for their production and use thereof in medicinal preparations
07/21/2010EP1399445B9 Substituted pyrroloquinolines and pyridoquinolines as serotonin agonists and antagonists
07/21/2010CN101784553A 3-spiropyrimidinetrione-quinoline derivatives and their use as antibacterial agents
07/21/2010CN101781314A Preparation process of levofloxacin hemihydrate
07/21/2010CN101781313A Method for synthesizing quinolone medicaments
07/20/2010US7759340 Antibacterial agents
07/20/2010US7759337 N-cyclopropyl-4-methyl-3-{1-[(2R)-2-methylpiperazin-1-yl]phthalazin-6-yl}benzamide, useful for the prophylaxis and treatment of protein kinase mediated diseases including rheumatoid arthritis, psoriasis and other inflammation disorders
07/15/2010WO2010057101A3 Compounds useful as hiv blockers
07/15/2010US20100179318 Process to make lestaurtinib
07/15/2010US20100179190 Bicyclic pyrazolo protein kinase modulators
07/15/2010US20100179135 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
07/15/2010US20100178294 Macrocyclic beta-secretase inhibitors
07/14/2010EP2206715A1 Fused heterotetracyclic compounds and use thereof as hcv polymerase inhibitor
07/14/2010EP2205599A1 Cgrp antagonists
07/14/2010EP1991223B1 Novel imidazolopyrazole derivatives useful as selective androgen receptor modulators
07/14/2010EP1863812B1 Dipeptidyl peptidase-iv inhibiting compounds, methods of preparing the same, and pharmaceutical compositions containing the same as an active agent
07/14/2010EP1551849B1 Tricyclic tetrahydroquinoline antibacterial agents
07/14/2010CN101775026A Spiro alkaloid compound, medicinal composition comprising same and preparation method and application thereof
07/13/2010US7754734 Administering one or more rapamycin derivatives (including rapamycin and 40-O-(2-hydroxy)ethyl-rapamycin); lymphocytic leukemia, lymphoma, Epstein-Barr virus, inhibiting graft rejection and metastasis; drug screening
07/13/2010CA2567776C Vasopressin v1a antagonists
07/13/2010CA2446820C Novel pyrrole derivatives as pharmaceutical agents
07/08/2010WO2010076418A1 Novel oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
07/08/2010WO2010056633A3 7-amino alkylidenyl-heterocyclic quinolones and naphthyridones
07/08/2010US20100174064 Forms of rifaximin and uses thereof
07/08/2010US20100173913 Pyrido-and pyrimidopyrimidine derivatives as anti-proliferative agents
07/08/2010US20100173902 Bicyclic amide derivatives for enhancing glutamatergic synaptic responses
07/08/2010US20100173890 Compounds, Process for their Preparation, Intermediates, Pharmaceutical Compositions and their use in the Treatment of 5-HT6 Mediated Disorders such as Alzheimer's Disease, Cognitive Disorders, Cognitive Impairment Associated with Schizophrenia, Obesity and Parkinson's Disease
07/08/2010CA2745503A1 Novel oxime derivatives of 3,5-seco-4-nor-cholestane, pharmaceutical compositions containing same, and method for preparing same
07/07/2010EP2203459A1 Spirocyclic aminoquinolones as gsk-3 inhibitors
07/07/2010EP2203458A2 Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors
07/07/2010CN101772504A substituted bicyclolactam compounds
07/07/2010CN101772493A gamma secretase modulators
07/07/2010CN101768173A Norcantharidin dimer derivate as well as synthetic method and application thereof
07/07/2010CN101768167A Method for synthesizing piperazine of levofloxacin
07/06/2010US7749997 Pyrimido [4,5-B] -Oxazines for use as DGAT inhibitors
07/06/2010US7749994 serine/threonine kinase inhibitors, useful for therapy and/or prophylaxis of cancers in mammals
07/01/2010WO2010075273A1 Bicyclic heterocycle derivatives and methods of use thereof
07/01/2010WO2010075204A2 Gamma secretase modulators
07/01/2010WO2010075203A1 Gamma secretase modulators
07/01/2010WO2010073034A1 Pyrimidine indole derivatives for treating cancer
07/01/2010WO2010036921A3 Slow release of organoboronic acids in cross-coupling reactions
07/01/2010US20100168107 Imidazole compounds for the treatment of neurodegenerative disorders
07/01/2010US20100168095 Multi-cyclic cinnamide derivatives
07/01/2010US20100168093 Substituted 3-amino-4 -hydroxy pyrrolidines compounds, their preparation and use as medicaments
07/01/2010US20100168091 Imidazole Amines As Inhibitors Of Beta-secretase
07/01/2010US20100168080 Novel compounds useful as cc chemokine receptor ligands
07/01/2010US20100163813 Long wavelength shifted benzotriazole uv-absorbers and their use
07/01/2010CA2772760A1 Small molecule inhibitors of necroptosis
07/01/2010CA2750841A1 Pyrimidine indole derivatives for treating cancer
07/01/2010CA2747750A1 Gamma secretase modulators
07/01/2010CA2747744A1 Gamma secretase modulators
06/2010
06/30/2010EP2200440A1 Antibacterial amide and sulfonamide substituted heterocyclic urea compounds
06/30/2010CN101759707A Heterocyclic ring substituent norcantharidin derivative and synthesis method and application thereof
06/30/2010CN101759645A P38 inhibitors and methods of use thereof
06/29/2010US7745457 Meridamycin analogues for the treatment of neurodegenerative disorders
06/24/2010WO2010071819A1 Bicyclic heterocyclic derivatives and methods of use thereof
06/24/2010WO2010071211A1 Cyclic carbodiimide compounds
06/24/2010WO2010070022A1 Novel compounds
06/24/2010WO2010069850A1 Macrolactone derivatives, method for the production thereof and use thereof for the treatment of cancer
06/24/2010US20100160626 Process For The Preparation Of 3,7-Dihydroxy-1,5-Diazacyclooctanes
06/24/2010US20100160403 Hcv ns3 protease inhibitors
06/24/2010US20100160330 Novel bicyclic heterocycles useful as selective androgen receptor modulators
06/24/2010US20100160313 Discovery of novel anticancer compounds based on conformational sampling of quinoxalinhydrazide pharmacophore
06/24/2010US20100160310 2,4 (4,6) pyrimidine derivatives
06/24/2010US20100160255 Spiro-cyclic compound
06/24/2010CA2746982A1 Cyclic carbodiimide compound
06/24/2010CA2744935A1 New compounds
06/23/2010EP2199295A1 Compounds with 7-member cycle and the pharmaceutical use thereof for preventing and treating diabetes and metabolism syndrome
06/23/2010EP2198858A1 Sustained release preparation of a macrolide compound like tacrolimus
06/23/2010EP2197884A2 Tetracyclic indole derivatives and their use for treating or preventing viral infections
06/23/2010CN101747320A Dialdehyde-built disinsection activity-having nitrogen or oxygen-containing heterocyclic compound and preparation method
06/22/2010US7741343 6H-oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
06/22/2010US7741339 Fab I inhibitors
06/22/2010US7741338 mixtures comprising a polyene macrolide antibiotic and an antioxidant such as 2,6-di-tert.-butyl-4-methylphenol, that improves the stability of the polyene macrolide to oxidation
06/22/2010US7741332 Brain and nervous system disorders such as mood disorders or urinary incontinence, pain, anxiety, hearing loss; 2-(carbonylamino)-1,1-dioxo-1H-benzo[1,2,4]thiadiazines, 4-(oxo or thiooxo)-3-(carbonylamino)-quinazolines, and 1-(oxo or thiooxo)-2-(carbonylamino)-1,2-dihydroisoquinolines
06/22/2010US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
06/22/2010US7741325 Benzo[b]chromeno-naphthyridin-7-one and pyrano[2′,3′:7,8]quino[2,3-b]quinoxalin-7-one compounds
06/22/2010CA2444198C Nociceptin analogs
06/22/2010CA2398988C Anti acid-fast bacterial agent containing pyridonecarboxylic acids as active ingredient
06/17/2010WO2010068453A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 220